RenovoRx, Inc. (RNXT) Financials
RNXT Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-09-30 | 3.5 million | 3.5 million |
| 2023-06-30 | 6.3 million | 5.1 million |
| 2023-03-31 | 4.6 million | 1.3 million |
| 2022-12-31 | 7.3 million | 1.1 million |
RNXT Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-09-30 | -2.7 million | 239000 |
| 2023-06-30 | -2.8 million | 257000 |
| 2023-03-31 | -2.7 million | 361000 |
| 2022-12-31 | -1.7 million | 164000 |
RNXT Net Income
No data available :(
RNXT Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-09-30 | 3.2 million | - | - |
| 2023-06-30 | 6.0 million | - | - |
| 2023-03-31 | 3.7 million | - | - |
| 2022-12-31 | 6.4 million | - | - |
RNXT Shares Outstanding
RNXT Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-09-30 | - | 1.6 million | 1.4 million | - |
| 2023-06-30 | - | 1.9 million | 1.5 million | - |
| 2023-03-31 | - | 1.3 million | 1.9 million | - |
| 2022-12-31 | - | 776000 | 1.4 million | - |
RNXT Cost of Revenue
No data available :(
RNXT
Price: $1.20
52 week price:
Earnings Per Share: -0.99 USD
P/E Ratio: -1.67
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 20500
Market Capitalization: 20.6 million